BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9809552)

  • 21. [Construction of expression plasmid for fused idiotypic DNA vaccine of B-cell lymphoma].
    Wang FX; Zhang Y; Zhao B; Pan L; Zhang XJ; Luo JM; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1453-8. PubMed ID: 20030925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccination against multiple myeloma.
    Stevenson FK; Link CJ; Traynor A; Yu H; Corr M
    Semin Hematol; 1999 Jan; 36(1 Suppl 3):38-42. PubMed ID: 9989489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiotypic vaccination in B-cell malignancies.
    Bianchi A; Massaia M
    Mol Med Today; 1997 Oct; 3(10):435-41. PubMed ID: 9358470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection.
    Syrengelas AD; Levy R
    J Immunol; 1999 Apr; 162(8):4790-5. PubMed ID: 10202021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model.
    Rinaldi M; Fioretti D; Iurescia S; Signori E; Pierimarchi P; Seripa D; Tonon G; Fazio VM
    Biochem Biophys Res Commun; 2008 May; 370(2):279-84. PubMed ID: 18364239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus type 16 E7 peptide(38-61) linked with an immunoglobulin G fragment provides protective immunity in mice.
    Qin Y; Wang XH; Cui HL; Cheung YK; Hu MH; Zhu SG; Xie Y
    Gynecol Oncol; 2005 Feb; 96(2):475-83. PubMed ID: 15661238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
    Wright P; Zheng C; Moyana T; Xiang J
    Cancer Gene Ther; 1998; 5(6):371-9. PubMed ID: 9917092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.
    Biragyn A; Tani K; Grimm MC; Weeks S; Kwak LW
    Nat Biotechnol; 1999 Mar; 17(3):253-8. PubMed ID: 10096292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding beta-galactosidase fused to an envelope protein of endogenous retrovirus.
    Takeda J; Sato Y; Kiyosawa H; Mori T; Yokoya S; Irisawa A; Miyata M; Obara K; Fujita T; Suzuki T; Kasukawa R; Wanaka A
    Cell Immunol; 2000 Aug; 204(1):11-8. PubMed ID: 11006013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant adenovirus vaccine encoding a chimeric T-cell antigen receptor induces protective immunity against a T-cell lymphoma.
    Wong CP; Levy R
    Cancer Res; 2000 May; 60(10):2689-95. PubMed ID: 10825142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell lymphoma idiotypes chimerized by gene targeting can induce tumor immunity.
    Selmayr M; Menzel H; Kremer JP; Thierfelder S; Mocikat R
    Cancer Gene Ther; 2000 Mar; 7(3):501-6. PubMed ID: 10766357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants.
    Benvenuti F; Burrone OR
    Gene Ther; 2001 Oct; 8(20):1555-61. PubMed ID: 11704816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Construction of a DNA vaccine against human B cell lymphoma].
    Zhang YS; Zhong KL; Yuan Y; Zhang MW; Zhang Y; Mao N
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):79-82. PubMed ID: 15182628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Specific humoral immune response against B-cell lymphoma elicited by mixed immunoglobulin fragments].
    Lin N; Zhu P; Zhang X; Dong Y; Ren Y; Wang Y; Li W
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):766-70. PubMed ID: 12126549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New strategies for vaccination and imunomodulation in NHL.
    Stevenson FK; Zhu D; Rice J
    Ann Hematol; 2001; 80 Suppl 3():B132-4. PubMed ID: 11757697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boosting anti-idiotype immune response with recombinant AAV enhances tumour protection induced by gene gun vaccination.
    Cesco-Gaspere M; Zentilin L; Giacca M; Burrone OR
    Scand J Immunol; 2008 Jul; 68(1):58-66. PubMed ID: 18482206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral immune responses induced by anti-idiotypic antibody fusion protein of 6B11scFv/hGM-CSF in BALB/c mice.
    Chang XH; Ye X; Cui H; Feng J; Li Y; Zhu HL; Yang WL; Fu TY; Cheng HY; Guo HF
    Chin Med J (Engl); 2006 Jan; 119(2):131-9. PubMed ID: 16454995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.